Frontlight ResearchEarly access
Trial site
South Texas Research Institute
- 7running trials
- 6closed trials
The trials here
What the 13 trials at this site are about, from their registry records.
- Conditions
- Fatty liver disease (MASLD/MASH)7 trials
- Liver cirrhosis4 trials
- Obesity3 trials
- Chronic kidney disease1 trial
- Coronary artery disease1 trial
- Heart failure1 trial
- High blood pressure1 trial
- Liver and biliary tract cancer1 trial
- Peripheral artery disease1 trial
- Stroke1 trial
- Type 2 diabetes1 trial
- Phase
- Phase 36 trials
- Phase 25 trials
- Phase 2/31 trial
- Status
- Active, not recruiting5 trials
- Completed4 trials
- Recruiting2 trials
- Terminated2 trials
- Lead sponsor
- Amgen2 trials
- Eli Lilly and Company2 trials
- Madrigal Pharmaceuticals, Inc.2 trials
- Novo Nordisk A/S2 trials
- Boehringer Ingelheim1 trial
- and 4 more
Running trials
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Fatty liver disease (MASLD/MASH)1 recruiting
- Liver and biliary tract cancer1 recruiting
- Liver cirrhosis1 recruiting
Closed trials
Recruiting
Completed
Completed
Completed
A Study to Assess the Safety, Efficacy, and Pharmacokinetics of Multiple Doses of ION224
Completed
Terminated
Site data: ClinicalTrials.govUpdated 18 Nov 2026